Last 25.00 INR
Change Today -0.50 / -1.96%
Volume 1.1K
ZTL On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

zenotech laboratories ltd (ZTL) Snapshot

Open
24.75
Previous Close
25.50
Day High
25.80
Day Low
24.25
52 Week High
05/8/14 - 36.15
52 Week Low
09/13/13 - 9.80
Market Cap
860.6M
Average Volume 10 Days
2.1K
EPS TTM
-3.64
Shares Outstanding
34.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ZENOTECH LABORATORIES LTD (ZTL)

Related News

No related news articles were found.

zenotech laboratories ltd (ZTL) Related Businessweek News

No Related Businessweek News Found

zenotech laboratories ltd (ZTL) Details

Zenotech Laboratories Limited, a pharmaceutical specialty generic injectables company, manufactures bio-technology products. It primarily serves niche therapy areas, including oncology and anesthesiology. The company was formerly known as Sunline Technologies Limited and changed its name to Zenotech Laboratories Limited in August 2004. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.

Founded in 1989

zenotech laboratories ltd (ZTL) Top Compensated Officers

Founder and Executive Director
Total Annual Compensation: 1.5M
Compensation as of Fiscal Year 2012.

zenotech laboratories ltd (ZTL) Key Developments

Zenotech Laboratories Limited Announces Board Changes

Zenotech Laboratories Ltd. announced that Dr. Junichi Koga has resigned from his office as director of the company effective from June 06, 2014. In consequence thereof, Dr. Sudershan Kumar Arora, Alternate Director to Dr. Junichi Koga, also vacates his office as Alternate Director.

Zenotech Laboratories Limited Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2014

Zenotech Laboratories Limited reported unaudited standalone earnings results for the fourth quarter and year ended March 31, 2014. For the quarter, the company reported net sales of INR 5.319 million against INR 2.349 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 33.957 million against INR 114.603 million a year ago. Loss from ordinary activities before tax was INR 26.084 million against INR 118.054 million a year ago. Net loss for the period was INR 26.084 million against INR 118.054 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.76 against INR 3.43 a year ago. For the year, the company reported net sales of INR 27.557 million against INR 30.441 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 205.558 million against INR 241.954 million a year ago. Loss from ordinary activities before tax was INR 228.554 million against INR 255.219 million a year ago. Net loss for the period was INR 228.554 million against INR 255.219 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 6.64 against INR 7.41 a year ago.

Zenotech Laboratories Limited to Report Fiscal Year 2014 Results on May 26, 2014

Zenotech Laboratories Limited announced that they will report fiscal year 2014 results on May 26, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZTL:IN 25.00 INR -0.50

ZTL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ZTL.
View Industry Companies
 

Industry Analysis

ZTL

Industry Average

Valuation ZTL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZENOTECH LABORATORIES LTD, please visit www.zenotechlabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.